May 2026 in “International Journal of Drug Delivery Technology” Using a 45-degree angle for hair transplants improves efficiency and results.
March 2026 in “Journal of medical & health sciences review.” Both 5% minoxidil foam and liquid effectively treat hair loss, with foam slightly preferred.
February 2026 in “Clinical and Experimental Dermatology” Bicalutamide improved hair growth more than spironolactone in women with hair loss.
February 2026 in “Clinical Traditional Medicine and Pharmacology” Both Unani treatments effectively reduced hair shedding in Telogen Effluvium.
January 2026 in “The FASEB Journal” The trial aims to test a new treatment for hair loss in young men using stem cell-derived vesicles.
January 2026 in “Medicine” Higher LDL cholesterol may increase the risk of hair loss, while HDL cholesterol does not.
January 2026 in “Frontiers in Digital Health” Motion-graphic videos improve patient understanding more than verbal explanations for platelet-rich plasma therapy.
January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Prachhanna followed by Guñjā lepa is more effective for treating alopecia areata than PRP with Minoxidil.
January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Prachhanna followed by Guñjā lepa is more effective for treating alopecia areata than PRP with Minoxidil.
January 2026 in “Dermatologic Therapy” 0.5% minoxidil mesotherapy is more effective and safe for hair growth in women with androgenetic alopecia than topical 2% minoxidil.
January 2026 in “Dermatologic Therapy” Combining laser treatment with minoxidil is more effective for hair growth in men than using minoxidil alone.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” Combining minoxidil with microneedling leads to better hair regrowth than using minoxidil alone.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” Combining microneedling with minoxidil leads to better hair regrowth than using minoxidil alone.
December 2025 in “Journal of Cosmetic Dermatology” Finasteride does not increase the risk of depression or suicide.
November 2025 in “International Journal of Research in Medical Sciences” Titagen® improves skin, hair, nail health, and reduces osteoarthritis symptoms safely.
November 2025 in “Frontiers in Nutrition” Olive leaf extract may help reduce aging signs in postmenopausal women.
November 2025 in “Clinical Cosmetic and Investigational Dermatology” Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.
November 2025 in “Journal of Multidisciplinary Healthcare” Combining fire needle therapy with doxycycline improves severe acne more than doxycycline alone.
September 2025 in “Clinics and Practice” Collagen with calcium and vitamin D improves bone health, skin elasticity, and reduces hair loss in menopausal women.
September 2025 in “Dermatologic Surgery” Combining radiofrequency with minoxidil is more effective for hair regrowth in women than using CO2 with minoxidil.
September 2025 in “Journal of the Egyptian Womenʼs Dermatologic Society” Using platelet-rich plasma for storing hair grafts improves hair regrowth and density.
Adding a topical agent to IPL improves hair reduction and satisfaction without extra side effects.
August 2025 in “Indian Dermatology Online Journal” Both treatments work equally well for hair regrowth, but the lotion has fewer side effects.
August 2025 in “Indian Dermatology Online Journal” Combining minoxidil with phototherapy improves vitiligo treatment better than phototherapy alone.
August 2025 in “Nutrients” Eating more antioxidant-rich foods and less alcohol may help reduce hair loss.
The 0.05% dutasteride topical solution effectively promotes hair growth with fewer side effects than oral treatments.
Biotin and silica from plants improve hair, skin, and nail health.
July 2025 in “Journal of Cosmetic Dermatology” Triamcinolone is more effective than methotrexate for treating localized alopecia areata.
July 2025 in “Clinical Cosmetic and Investigational Dermatology” Major depression disorder increases the risk of alopecia areata, and vice versa.
June 2025 in “British Journal of Dermatology” Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.